Sanofi to boost volumes as price control hits margins

With price controls continuing to crimp margins, Sanofi India expects a muted growth in the domestic market in 2017 and therefore will be focusing on volumes as well as exports. “We expect to continue to face annualised negative impact of price cuts imposed in 2016. Due to this reason, growth of domestic business will be muted in value terms in 2017. Therefore our focus will be to drive the volume growth as well as exports, which is likely to grow steadily,” Sanofi India said in its annual report for 2016.